✨ Free AI Report
AMICUS THERAPEUTICS, INC.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research AMICUS THERAPEUTICS, INC.
Company Research

AMICUS THERAPEUTICS, INC.: Business Overview, Financials & Competitive Analysis

AMICUS THERAPEUTICS, INC. is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative therapies for patients living with rare and orphan diseases. Founded in 2002,...

Analyst-debate audio for AMICUS THERAPEUTICS, INC.

AskCyborg analysts argue the bull and bear cases for AMICUS THERAPEUTICS, INC. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Company OverviewProduct PortfolioLeadership and Management TeamFinancial OverviewMarketing StrategiesMarket Overview and Competitors
Get Interactive Report Freeor start reading below
Live on AskCyborg
7/10Strong
Amicus Therapeutics, Inc.

Strong rare disease biotech with accelerating revenue growth, validated products, and strategic acquisition upside at $14.50/share.

▶︎ Listen to the 90-second analyst debate
Competitors covered:Sanofi S.A.
7/ 10Strong

Cyborg Score thesis

Strong rare disease biotech with accelerating revenue growth, validated products, and strategic acquisition upside at...

Read the full analyst-debate transcript →
Industry Biotechnology - Rare/Orphan Diseases, Lysosomal Storage Disorders
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest AMICUS THERAPEUTICS, INC. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

AMICUS THERAPEUTICS, INC. is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative therapies for patients living with rare and orphan diseases. Founded in 2002, the company has become a leader in the biotech industry, known for its commitment to patient-centric care and groundbreaking approaches in genetic medicine.

Company Overview

Pro stress-test →

AMICUS THERAPEUTICS, INC. focuses on developing advanced therapies that address unmet medical needs. With a robust pipeline of clinical and preclinical programs, the company aims to provide life-changing treatments for patients with rare diseases. Their headquarters are located in Cranbury, New Jersey, and they have a global presence with operations in multiple countries.

Product Portfolio

Pro stress-test →

AMICUS THERAPEUTICS, INC. has a diverse portfolio of products and services, including:

  • Galafold® (migalastat): A precision medicine for Fabry disease, designed to treat patients with amenable mutations.
  • AT-GAA: An investigational therapy targeting Pompe disease, currently in late-stage clinical development.
  • Gene Therapy Programs: Innovative gene therapy initiatives focused on lysosomal storage disorders and other rare diseases.

Leadership and Management Team

Pro stress-test →

The leadership at AMICUS THERAPEUTICS, INC. is comprised of experienced professionals dedicated to advancing the company’s mission. Key members include:

  • John F. Crowley: Chairman and CEO, known for his visionary leadership and personal commitment to rare disease research.
  • Bradley L. Campbell: President and Chief Operating Officer, with extensive experience in the biopharmaceutical industry.
  • William D. Baird III: Chief Financial Officer, responsible for the company’s financial strategy and operations.

Financial Overview

AMICUS THERAPEUTICS, INC. has demonstrated strong financial performance, with significant investments in research and development. Key financial metrics include:

  • Revenue Growth: Consistent year-over-year revenue increases driven by the success of Galafold®.
  • R&D Investment: Significant allocation of resources towards advancing their pipeline and expanding their gene therapy programs.
  • Market Capitalization: A solid market presence with a competitive market capitalization in the biotech sector.

Marketing Strategies

The company employs a comprehensive marketing strategy that includes:

  • Patient Advocacy: Partnering with patient organizations to raise awareness and support for rare diseases.
  • Digital Marketing: Utilizing digital platforms to engage with healthcare professionals and patients.
  • Global Outreach: Expanding their presence in international markets through strategic partnerships and collaborations.

Market Overview and Competitors

AMICUS THERAPEUTICS, INC. operates in a competitive market landscape, facing competition from both established pharmaceutical companies and emerging biotech firms. Key competitors include:

  • Sanofi Genzyme
  • BioMarin Pharmaceutical Inc.
  • Vertex Pharmaceuticals

Sales Strategies

The company’s sales strategies are designed to maximize market penetration and include:

  • Direct Sales Force: An experienced team dedicated to promoting their products to healthcare providers.
  • Strategic Partnerships: Collaborations with global pharmaceutical companies to enhance distribution.
  • Patient Support Programs: Initiatives to support patients in accessing and adhering to their treatment regimens.

Technologies Utilized

AMICUS THERAPEUTICS, INC. leverages cutting-edge technologies to advance their research and development, including:

  • Gene Editing: Utilizing CRISPR and other gene-editing technologies to develop novel therapies.
  • Biologics Manufacturing: Advanced manufacturing techniques to produce high-quality biologic products.
  • Precision Medicine: Tailoring treatments to individual genetic profiles for improved efficacy and safety.

HR Practices

The company is committed to fostering a supportive and inclusive work environment. Key HR practices include:

  • Employee Development: Offering continuous learning and development opportunities for employees.
  • Diversity and Inclusion: Promoting a diverse and inclusive workplace culture.
  • Employee Wellness: Implementing programs to support the physical and mental well-being of employees.

Corporate Responsibility

AMICUS THERAPEUTICS, INC. is dedicated to corporate social responsibility, with initiatives that include:

  • Environmental Sustainability: Efforts to reduce their environmental footprint through sustainable practices.
  • Community Engagement: Supporting local communities through charitable contributions and volunteer programs.
  • Ethical Business Practices: Maintaining high ethical standards in all business operations.

Future Plans

The future of AMICUS THERAPEUTICS, INC. is focused on growth and innovation. Key future plans include:

  • Pipeline Expansion: Continuing to advance their pipeline with new therapeutic candidates.
  • Global Expansion: Increasing their presence in international markets.
  • Technological Innovation: Investing in new technologies to enhance their research and development capabilities.

This detailed company summary provides a glimpse into the remarkable story of AMICUS THERAPEUTICS, INC. For a more comprehensive analysis and in-depth insights, consider purchasing our full report.


Get the full AMICUS THERAPEUTICS, INC. Research Report by subscribing

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on AMICUS THERAPEUTICS, INC..

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when AMICUS THERAPEUTICS, INC. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare AMICUS THERAPEUTICS, INC. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

AMICUS THERAPEUTICS, INC. operates in Biotechnology - Rare/Orphan Diseases, Lysosomal Storage Disorders. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Rare/Orphan Diseases, Lysosomal Storage Disorders research →
NEW · MCP server

Ask your AI assistant about AMICUS THERAPEUTICS, INC.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare AMICUS THERAPEUTICS, INC. and its top competitor on Cyborg Score”
“What did AMICUS THERAPEUTICS, INC. do this quarter?”
“Is AMICUS THERAPEUTICS, INC. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does AMICUS THERAPEUTICS, INC. do?+
AMICUS THERAPEUTICS, INC. is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative therapies for patients living with rare and orphan diseases. Founded in 2002,...
What is AMICUS THERAPEUTICS, INC.'s Cyborg Score?+
AMICUS THERAPEUTICS, INC. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are AMICUS THERAPEUTICS, INC.'s main competitors?+
Named competitors include Vimizim, Cerdelga, Enzyme Replacement Therapies. The full competitive landscape is in the AskCyborg report.
How can I get the full AMICUS THERAPEUTICS, INC. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the AMICUS THERAPEUTICS, INC. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track AMICUS THERAPEUTICS, INC. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Company Research

Gambling and Lotteries Industry BriefingStationery and Office Products Industry BriefingDefense Tech Industry BriefingAi Infrastructure Systems Industry BriefingPet Insurance Industry BriefingSelf-Storage Industry BriefingMetal Additive Manufacturing Industry BriefingAi Accelerator Hardware Systems Industry BriefingLuxury Wines & Spirits Industry BriefingEnzymatic Plastic Recycling Industry BriefingInfrastructure as a Service (IaaS) Industry Briefingluxury fashion apparel Industry Briefing

Explore Industry Research

Travel Insurance Industry Company Research ReportSecurity Services Industry Company Research ReportLandscaping and Grounds Maintenance Industry Company Research ReportJanitorial and Cleaning Services Industry Company Research ReportSustainability Consulting Industry Company Research ReportReal Estate Investment Trusts (REITs) Industry Company Research Report
Browse All Company ResearchBrowse All Industry ResearchRSS Feed